Uppsala University's award for successful knowledge transfer, "hjärnäpplet", has been awarded to OssDsign co-founder Håkan Engqvist, professor of applied material science.
OssDsign has been nominated for the German AGS Innovation Award 2018. The award is a yearly initiative from the German SPD's entrepreneurial branch AGS. This years nominees were recognised for their excellence in innovation and sustainability and OssDsign is being nominated based on "their groundbreaking medical technology that enables bone regeneration in the skull and face".
Hennepin County Medical Center has become one of the first in the United States to use OssDsign technology to create craniofacial bone replacements made of calcium phosphate and 3D-printed titanium that fit precisely in patients.
Aaron Jennings has been through quite a journey with his health and after another surgery 3 weeks ago, he remains strong and healthy and is enjoying time as a father and husband. His story is pretty unique as he's been able to use some of the products his company makes in his latest surgery as well as be on the forefront of medical innovation by staying in touch with his industry connections.
In a retrospective study of patients undergoing cranioplasty using OSSDSIGN Cranial, 96,7% of patients treated showed no signs of post-operative complications leading to implant
removal at an average follow-up time of 9,5 months. This indicates that OSSDSIGN Cranial may provide a better, more permanent solution for cranioplasty, even in
a complex patient population.
Professors Håkan Engqvist and Jöns Hillborn tell the story of how ceramic materials and polymers can be used to regenerate bone tissue.
We will be exhibiting at these meetings during 2016. Come and talk to us and find out more about our commitment to improve outcomes in cranioplasty and reconstructive facial surgery.
Clinical publication in Plastic and Reconstructive Surgery - Global Open, showing long-term outcome of the use of OSSDSIGN Cranial PSI for hemicraniectomy. See link for full text open access at PRS Global Open.
(Plastic and Reconstructive Surgery - Global Open:August 2015 - Volume 3 - Issue 8 - p e491doi: 10.1097/GOX.0000000000000467)
UPPSALA - November 4, 2015. OssDsign AB today announced that it has successfully raised SEK 93 million (EUR 9.6 million), in a new equity financing. The financing is led by the new investors SEB Venture Capital and Fouriertransform with continued investment from Karolinska Development. The proceeds will be used for the market expansion of OssDsign's product line of unique craniofacial implants based on an innovative material technology with excellent biological and biomechanical properties.